Passa al contenuto principale
  • Sign in
    Welcome !
    My account
    Logout

PROCEPT BioRobotics Corp (PRCT) Stock Forecast 2025 - AI Price Prediction & Analysis

PROCEPT BioRobotics Corp (PRCT) AI Stock Price Forecast & Investment Analysis

PROCEPT BioRobotics Corp Stock Price Chart and Technical Analysis

Loading PROCEPT BioRobotics Corp interactive price chart and technical analysis...

PROCEPT BioRobotics Corp (PRCT) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

PROCEPT BioRobotics Corp (Stock Symbol: PRCT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry. The organization employs approximately 360 professionals worldwide . The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Financial Performance & Key Metrics Analysis

Annual Revenue: $274 million generating a -58,4% net profit margin .

Market Capitalization: $2136 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -25,4% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for PROCEPT BioRobotics Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

PROCEPT BioRobotics Corp strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share . The company maintains a healthy 54,7% gross margin, indicating strong pricing power and operational efficiency.

PROCEPT BioRobotics Corp (PRCT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for PROCEPT BioRobotics Corp stock analysis.

Loading PROCEPT BioRobotics Corp comprehensive fundamental analysis and insider trading data...

Deep dive into PROCEPT BioRobotics Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if PROCEPT BioRobotics Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For PROCEPT BioRobotics Corp: With a P/E ratio of -45,40, the market sees the stock as potentially undervalued.

P/E Ratio -45,40x
P/B Ratio 5,54x
Market Cap $2136M
EPS $-1,54
Book Value/Share $6,94
Revenue/Share $4,95
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently PROCEPT BioRobotics Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For PROCEPT BioRobotics Corp: An ROE of -25,4% indicates room for improvement in shareholder value creation.

ROE -25,4%
ROA -20,0%
ROIC -19,1%
Gross Margin 54,7%
Operating Margin -62,1%
Net Margin -58,4%
EBT Margin -154,8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess PROCEPT BioRobotics Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For PROCEPT BioRobotics Corp: A current ratio of 20,87 indicates strong liquidity.

Current Ratio 20,87x
Quick Ratio 19,74x
D/E Ratio 0,20x
Financial Leverage 1,27x
Interest Coverage -10,1x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal PROCEPT BioRobotics Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For PROCEPT BioRobotics Corp: Free cash flow of $-61M indicates cash challenges that need attention.

Operating Cash Flow $-60M
Free Cash Flow $-61M
Capital Spending $-1M
FCF/Sales -147,0%
CapEx/Sales 1,5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively PROCEPT BioRobotics Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For PROCEPT BioRobotics Corp: An asset turnover of 0,13x suggests room for improvement in asset utilization.

Asset Turnover 0,13x
Receivables Turnover 5,9x
Inventory Turnover 1,6x
Fixed Assets Turnover 5,6x
Days Sales Outstanding 62 days
Days Inventory 224 days
Payables Period 45 days
Cash Conversion Cycle 241 days
Understanding Financial Statement Data

What these metrics mean: Key figures from PROCEPT BioRobotics Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For PROCEPT BioRobotics Corp: With annual revenue of $274M, PROCEPT BioRobotics Corp demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $274M
R&D Expense $62M
SG&A Expense $142M
Cost of Goods Sold $80M
Balance Sheet Highlights ($ Millions)
Total Current Assets $96M
Cash & Short-term Investments $89M
Total Liabilities $21M
Accounts Receivable $2M
Inventory $4M
Dividend & Shareholder Information
Shares Outstanding 56M
Growth Metrics (YoY)
EPS Growth -2,6%

Latest PROCEPT BioRobotics Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting PROCEPT BioRobotics Corp (PRCT) stock price and investment outlook.

📰 We are currently updating our news feed for PROCEPT BioRobotics Corp. Check back soon for the latest market analysis and company updates.

PROCEPT BioRobotics Corp Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of PROCEPT BioRobotics Corp against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast $25M x 2,9x
AEMD Unlock Forecast $3M -0,1x 0,7x
AFIB Unlock Forecast $0M 0,0x -0,4x
ALUR Unlock Forecast $17M -0,4x -0,3x
AMIX Unlock Forecast $4M x 0,5x
ANGO Unlock Forecast $421M -1,4x 2,3x
ANIK Unlock Forecast $135M -4,3x 0,9x
AORT Unlock Forecast $1911M -198,2x 4,6x
APYX Unlock Forecast $77M -3,5x 10,7x
ARAY Unlock Forecast $138M -9,9x 2,8x
ATEC Unlock Forecast $2333M -7,4x 98,2x
ATRC Unlock Forecast $1728M -39,6x 3,7x
AVGR Unlock Forecast $2M -1,3x 0,4x
AVHHL Unlock Forecast $20M x x
BAX Unlock Forecast $12378M -94,9x 1,7x
BBNX Unlock Forecast $855M x 2,8x
BDX Unlock Forecast $54739M 34,5x 2,2x
BEAT Unlock Forecast $46M -5,7x 11,0x
BEATW Unlock Forecast $15M x 3,2x
BJDX Unlock Forecast $2M -0,5x 0,4x
BLAC Unlock Forecast $12M x -2,1x
BLACR Unlock Forecast $1M x -0,2x
BLACU Unlock Forecast $14M x -2,4x
BLACW Unlock Forecast $0M x 0,0x
BSX Unlock Forecast $160575M 64,1x 7,2x
BTCY Unlock Forecast $10M -2,7x -0,1x
BVS Unlock Forecast $635M -18,3x 3,9x
CARL Unlock Forecast $-19M x x
CERS Unlock Forecast $235M -13,8x 4,2x
CLPT Unlock Forecast $298M -23,5x 15,1x
CODX Unlock Forecast $12M -0,7x 0,3x
CTCX Unlock Forecast $5M -0,2x -1,2x
CTCXW Unlock Forecast $1M x -0,2x
CTSO Unlock Forecast $64M -1,8x 4,4x
CVRX Unlock Forecast $205M -5,5x 3,5x
DCTH Unlock Forecast $440M 197,0x 4,2x
DHAI Unlock Forecast $10M x -0,3x
DHAIW Unlock Forecast $1M x 0,0x
DRIO Unlock Forecast $30M 0,6x 0,4x
DRTS Unlock Forecast $291M x 3,4x
DXCM Unlock Forecast $32184M 56,3x 12,5x
EBRCZ Unlock Forecast $246M x 5,0x
EMBC Unlock Forecast $572M 15,8x -0,8x
FEMY Unlock Forecast $12M -1,4x 7,7x
FNA Unlock Forecast $1098M -15,4x 8,4x
FOFA Unlock Forecast $9M x 17,0x
GCTK Unlock Forecast $2M 0,9x -0,5x
GIPL Unlock Forecast $5M x 27,9x
GKOS Unlock Forecast $5379M -46,3x 7,0x
GMED Unlock Forecast $8274M 23,2x 1,9x
GUTS Unlock Forecast $88M x 13,8x
HAE Unlock Forecast $3541M 26,1x 4,3x
HRGN Unlock Forecast $21M x 28,0x
IART Unlock Forecast $1125M 200,2x 1,1x
ICAD Unlock Forecast $106M -3,1x 3,5x
ICCM Unlock Forecast $66M x 22,7x
ICU Unlock Forecast $8M -1,1x 13,3x
ICUCW Unlock Forecast $0M x -0,1x
ICUI Unlock Forecast $3248M -49,8x 1,6x
IDXG Unlock Forecast $23M 4,5x -0,9x
IINN Unlock Forecast $28M x 6,5x
IINNW Unlock Forecast $8M x 1,8x
INBS Unlock Forecast $11M -0,3x 3,7x
INFU Unlock Forecast $229M 45,3x 4,2x
INSP Unlock Forecast $2609M 49,1x 3,9x
IRMD Unlock Forecast $903M 43,7x 9,6x
IRTC Unlock Forecast $5493M -20,2x 53,0x
IVF Unlock Forecast $1M x 0,3x
KIDS Unlock Forecast $499M -20,7x 1,4x
KMTS Unlock Forecast $829M x x
KRMD Unlock Forecast $195M -19,8x 11,8x
LMAT Unlock Forecast $0M 58,7x 0,0x
LNSR Unlock Forecast $59M -6,7x -7,0x
LUCD Unlock Forecast $128M -0,6x 16,3x
LUNG Unlock Forecast $70M -4,3x 1,0x
LYRA Unlock Forecast $524M -0,1x 135,2x
MBOT Unlock Forecast $92M -1,3x 3,2x
MCAG Unlock Forecast $22M x -9,6x
MCAGU Unlock Forecast $21M x -9,9x
MDAI Unlock Forecast $69M -1,3x -42,3x
MDAIW Unlock Forecast $9M x -2,1x
MDNC Unlock Forecast $59M 26,8x 13,4x
MDXG Unlock Forecast $1062M 33,0x 4,9x
MGRM Unlock Forecast $209M -10,7x 24,3x
MHUA Unlock Forecast $13M x 0,1x
MMM Unlock Forecast $83895M 21,3x 19,6x
MMSI Unlock Forecast $5526M 46,4x 3,7x
MODD Unlock Forecast $38M -2,1x 2,2x
NARI Unlock Forecast $4677M -51,9x 10,8x
NAYA Unlock Forecast $2M -0,3x 0,2x
NEPH Unlock Forecast $39M -20,3x 2,0x
NMTC Unlock Forecast $38M -1,7x 4,7x
NPCE Unlock Forecast $302M -10,4x 15,6x
NSPR Unlock Forecast $123M -4,3x 6,1x
NURO Unlock Forecast $9M -0,5x 0,7x
NVAC Unlock Forecast $69M 84,3x -13,6x
NVACR Unlock Forecast $1M x -0,1x
NVACW Unlock Forecast $0M x 0,0x
NVCR Unlock Forecast $1334M -20,8x 3,8x
NVNO Unlock Forecast $87M -2,0x 2,3x
NVRO Unlock Forecast $221M -2,1x 1,0x
NXGL Unlock Forecast $20M -6,8x 4,4x
NXGLW Unlock Forecast $3M x 0,7x
OBIO Unlock Forecast $118M -3,4x 2,0x
OFIX Unlock Forecast $591M -5,8x 1,3x
OSRH Unlock Forecast $26M x 0,3x
OSUR Unlock Forecast $247M 17,1x 0,7x
PAVM Unlock Forecast $22M 0,3x 0,6x
PAVMZ Unlock Forecast $0M x 0,0x
PDEX Unlock Forecast $158M 16,8x 4,5x
PEN Unlock Forecast $10568M 71,6x 8,2x
PETV Unlock Forecast $18M -1,4x 12,0x
PLSE Unlock Forecast $1016M -2,6x 8,6x
PODD Unlock Forecast $24267M 102,8x 16,6x
PRCT Unlock Forecast $2136M -45,4x 5,5x
PROF Unlock Forecast $134M x 3,4x
PSTV Unlock Forecast $12M -0,3x -0,5x
PYPD Unlock Forecast $52M x 2,6x
RCEL Unlock Forecast $115M -5,0x -29,9x
RDGL Unlock Forecast $51M x 18,9x
RMD Unlock Forecast $39665M 28,3x 6,7x
RSMDF Unlock Forecast $2450M 1,8x 0,4x
RTGN Unlock Forecast $66M x x
RVP Unlock Forecast $25M -0,9x 0,3x
SGHT Unlock Forecast $211M -3,7x 3,0x
SIBN Unlock Forecast $717M -14,3x 4,2x
SINT Unlock Forecast $7M -0,5x 1,1x
SKIN Unlock Forecast $292M -1,8x 4,0x
SNOA Unlock Forecast $7M -5,6x 1,8x
SNWV Unlock Forecast $357M x -19,4x
SOLV Unlock Forecast $12569M 33,1x 3,5x
SRDX Unlock Forecast $432M -79,3x 3,9x
SRTS Unlock Forecast $56M 31,6x 1,1x
SSII Unlock Forecast $1535M x 37,9x
SSKN Unlock Forecast $10M -8,0x 32,2x
STIM Unlock Forecast $256M -1,0x 9,4x
STME Unlock Forecast $12M x x
STSS Unlock Forecast $14M -2,5x 1,0x
STSSW Unlock Forecast $0M x 0,0x
SYK Unlock Forecast $140684M 42,0x 12,0x
TCMD Unlock Forecast $315M 20,9x 1,6x
TELA Unlock Forecast $81M -1,8x 8,8x
TFX Unlock Forecast $5732M 29,9x 1,4x
TLSI Unlock Forecast $191M -3,6x -5,6x
TLSIW Unlock Forecast $66M x -1,9x
TMCI Unlock Forecast $628M -7,5x 6,0x
TNDM Unlock Forecast $845M -17,1x 6,3x
TNON Unlock Forecast $9M -0,3x 1,4x
TNONW Unlock Forecast $0M x 0,0x
TTOO Unlock Forecast $4M 0,0x -0,3x
UFPT Unlock Forecast $1757M 44,7x 4,9x
USAQ Unlock Forecast $2M x x
UTMD Unlock Forecast $204M 16,2x 1,7x
VERO Unlock Forecast $5M 0,0x 2,1x
VTAK Unlock Forecast $3M 0,0x 0,3x
VVOS Unlock Forecast $21M -0,5x 2,8x
WST Unlock Forecast $17744M 36,4x 6,1x
XAIR Unlock Forecast $303M -0,3x 22,3x
XTNT Unlock Forecast $95M -478,8x 2,0x

Frequently Asked Questions - PROCEPT BioRobotics Corp Stock Forecast

How accurate are PROCEPT BioRobotics Corp stock predictions?

Our AI model demonstrates -4% historical accuracy for PRCT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence PROCEPT BioRobotics Corp stock price forecasts?

Our analysis considers PROCEPT BioRobotics Corp's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is PROCEPT BioRobotics Corp a good investment in 2025?

Based on our AI analysis, PROCEPT BioRobotics Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are PROCEPT BioRobotics Corp forecasts updated?

PROCEPT BioRobotics Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced PROCEPT BioRobotics Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for PROCEPT BioRobotics Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...